The EPICOR study reveals significant regional variations and room for improvement in the pre-hospital and in-hospital use of anti-thrombotic drugs and reperfusion strategies for ACS patients.
No takes yet. Share an insight, caveat, or question.
Regional disparities in ACS antiplatelet and reperfusion use persist; leaves open whether targeted initiatives can standardize care.
Bueno et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: